These data are in concordance with the results of other clinical and experimental studies,27–31 which demonstrated the utility of nephrin and VEGF as early biomarkers of diabetic nephropathy or as predictors of the development of renal insufficiency in the stage of normoalbuminuria. The gene discussed is NPHS1; the disease is diabetic kidney disease.